Since Covid, health has moved to the centre of how people think, not just for the ageing population, but across every age group. Prevention, biomarkers, sleep, recovery, longevity clinics, longevity supplements, longevity retreats: it's become one of the most-used words in wellness. For operators and investors in hospitality and wellness, that popularity has created real opportunity, and real confusion. What exactly is a "longevity" offering, and what separates a serious clinical proposition from a spa with a new name on the door?
Dubai has just given the market its clearest answer yet.
What changed: the Dubai Longevity Authority
Under Law No. 17 of 2026, Dubai established the Dubai Longevity Authority (DLA), a dedicated regulator tasked with building a science-based framework for the longevity sector, with clear ambitions for what that framework should achieve for the emirate.
Practically, that means dedicated licensing and oversight specific to longevity therapies, stronger compliance requirements aligned with international healthcare and patient-safety standards, and formal supervision of clinical trials and advanced therapies, including emerging biotechnology. The DLA sits alongside existing Dubai healthcare licensing (DHA and related authorities), not in place of it.
In short: longevity in Dubai is no longer whatever an operator chooses to call it. It is a regulated category with a licensing authority behind it.
Why this matters beyond Dubai
Regulatory leaders tend to set the bar others eventually follow, particularly in healthcare-adjacent sectors. The DLA's own leadership has been explicit about what they're building.
"The establishment of the Dubai Longevity Authority will offer regulatory certainty across the entire value chain, from R&D and clinical trials through to manufacturing, delivery, and patient care. What we are building is a sophisticated, sovereign market for advanced therapeutic products and services." - Helal Saeed Almarri, Chairman, Dubai Longevity Authority, and Director General, Dubai Department of Economy and Tourism (WAM, 10 June 2026)
For operators and investors, that's a government positioning this as durable market infrastructure, not a temporary compliance exercise. For consumers, it may matter even more. In an extreme case, a building can carry a spa sign on the door one month and a longevity sign the next, without major change to the people, processes, or facilities behind it. The DLA sets an enforceable standard for that: the qualifications of the people delivering treatment, the protocols they follow, and the infrastructure they operate in all now must meet a defined bar.
"When a sector moves from self-regulation to licensed oversight, capital pays attention. This isn't a Dubai story, but an early signal for the whole industry." - Roger Allen, Group CEO, RLA Global
Two tracks for operators and investors
The DLA's arrival changes the calculation differently depending on where you are starting from. Broadly, there are two tracks.
1. Building new
This covers ground-up development: a purpose-built longevity clinic, or a longevity-hospitality proposition, where guests stay on-site while undergoing treatment, blending hospitality infrastructure with clinical delivery. For this group, the DLA changes the starting line. Licensing now needs to be sequenced from day one alongside DHA requirements, clinical governance and treatment protocols need to be built to a defined regulatory standard rather than an internal one, and the investment case can lean on regulation as a confidence signal for capital, not simply a compliance cost.
"I'm glad there will be a standard now. When someone puts their health in your hands, they deserve to know exactly what they're getting, not just a nice word on a brochure. A real standard protects the patient, and it protects the doctors who have always taken this seriously. It’s about professionalism, trust and feeling safe and that is most important for all involved. " - Dr Maria, Founder, Maison Sante
2. Transforming what you already have
This is the larger and more immediate group: operators sitting on an existing asset and an existing client base, considering a shift in positioning. It covers several variants. A wellness or spa destination repositioning toward longevity needs to close the gap between what it already offers and what DLA licensing will expect in terms of clinical oversight and patient safety. A private hospital expanding its services into prevention and longevity is starting from a stronger regulatory base, with the clinical infrastructure already in place, but faces a different challenge: building a wellness experience compelling enough to sit alongside that clinical credibility. A social wellness hub adding a longevity component needs to be honest about how much of its existing offering can credibly sit under a longevity licence, and how much cannot.
For the wellness, spa and social-hub variants, the common risk is relabelling without the clinical substance to back it up, and the DLA framework makes that gap far more visible than it has been until now. For hospitals, the challenge runs the other way: they already have the clinical rigour, what they need to prove is that the guest experience can match it.
Why this is genuinely new
Longevity has typically sat in a grey zone, part medical, part lifestyle, part hospitality, without one authority owning the whole category. Dubai has done something structurally different: it built a dedicated authority for longevity itself, with oversight running end to end, from research and clinical trials through to the clinic delivering treatment.
That's a structural choice, not just a labelling one, and it's a precedent worth watching. Not because Dubai got there first with a good idea, but because it addressed something most markets haven't formally addressed at all.
What operators and investors are really asking right now
- Does this change my investment case, and in which direction?
- Who do I partner with clinically, and how do I know they're credible?
- Is my brand strong enough to carry a longevity positioning, or does this new bar work against me?
- Do I move first, or wait and see how enforcement actually plays out?
- What does "getting this right" now cost me that it didn't a year ago?
The bottom line
"Our ambition is for Dubai to become the world's leading hub for longevity, wellness and advanced healthcare, and to set new global benchmarks in health and quality of life." - His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai (WAM, 10 June 2026)
Longevity has spent the last few years as a trend. Dubai has just treated it as a healthcare category worth regulating properly, and that shift is likely to ripple well beyond Dubai's own borders. For operators and investors weighing a move into this space, whether building from the ground up or repositioning an existing destination, the sector has just become more serious, more scrutinised, and, for those who get it right, considerably more credible.
RLA Global advises operators, investors and developers on exactly this decision, from feasibility through to positioning and licensing strategy, across both greenfield longevity developments and repositioning projects.
Get in touch to talk through what this means for your plans. contactus@rlaglobal.com
Image: Maison Santé Clinic, Dubai
